Article Versions Notes

Varedi A, Rahman H, Kumar D, Catrow JL, Cox JE, Liu T, Florell SR, Boucher KM, Okwundu N, Burnett WJ, et al. ASA Suppresses PGE₂ in Plasma and Melanocytic Nevi of Human Subjects at Increased Risk for Melanoma. Pharmaceuticals. 2020; 13(1):7. https://doi.org/10.3390/ph13010007

Varedi, Amir, Hafeez Rahman, Dileep Kumar, Jonathan L. Catrow, James E. Cox, Tong Liu, Scott R. Florell, Kenneth M. Boucher, Nwanneka Okwundu, William J. Burnett, and et al. 2020. "ASA Suppresses PGE₂ in Plasma and Melanocytic Nevi of Human Subjects at Increased Risk for Melanoma" Pharmaceuticals 13, no. 1: 7. https://doi.org/10.3390/ph13010007

Varedi, A., Rahman, H., Kumar, D., Catrow, J. L., Cox, J. E., Liu, T., Florell, S. R., Boucher, K. M., Okwundu, N., Burnett, W. J., VanBrocklin, M. W., & Grossman, D. (2020). ASA Suppresses PGE₂ in Plasma and Melanocytic Nevi of Human Subjects at Increased Risk for Melanoma. Pharmaceuticals, 13(1), 7. https://doi.org/10.3390/ph13010007